Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam toluene sulfonate for painless bronchoscopy in children
ChiCTR2400094685Phase 4Not yet recruiting
- Sponsor
- Hunan Children's Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam in pulmonary infection, sponsored by Hunan Children's Hospital. Primary endpoints: MOAA/S scale and ED50 and ED95 of remimazolam. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on ChiCTR2400094685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094685.